Network analysis identifies proinflammatory plasma cell polarization for secretion of isg15 in human autoimmunity

Journal of Immunology

Volumn 197, Issue 4, 2016, Pages 1447-1459

  Care, Matthew A ^a,b   Stephenson, Sophie J ^a   Barnes, Nicholas A ^a   Fan, Im ^c   Zougman, Alexandre ^a   El Sherbiny, Yasser M ^a,c   Vital, Edward M ^a,c   Westhead, David R ^b   Tooze, Reuben M ^a,c   Doody, Gina M ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CELL PROTEIN; IMMUNOGLOBULIN; INTERFERON STIMULATED GENE 15 PROTEIN; UNCLASSIFIED DRUG; CYTOKINE; ISG15 PROTEIN, HUMAN; TRANSCRIPTOME; UBIQUITIN;

ARTICLE; AUTOIMMUNITY; CELL POLARIZATION; CELLULAR PARAMETERS; CELLULAR SECRETION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOMODULATION; INFLAMMATION; INTRACELLULAR CONJUGATION; PLASMA CELL; PLASMABLAST; PRIORITY JOURNAL; PROTEIN SECRETION; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION REGULATION; CYTOLOGY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; IMMUNOLOGY; SECRETION (PROCESS); WESTERN BLOTTING;

AUTOIMMUNITY; BLOTTING, WESTERN; CYTOKINES; ENZYME-LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; PLASMA CELLS; TRANSCRIPTOME; UBIQUITINS;

EID: 84983761122     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600624     Document Type: Article

References (79)

1. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230.
2. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
3. Fritz, J. H., O. L. Rojas, N. Simard, D. D. McCarthy, S. Hapfelmeier, S. Rubino, S. J. Robertson, M. Larijani, J. Gosselin, I. I. Ivanov, et al. 2011. Acquisition of a multifunctional IgA+ plasma cell phenotype in the gut. Nature 481: 199-203.
4. Bermejo, D. A., S. W. Jackson, M. Gorosito-Serran, E. V. Acosta-Rodriguez, M. C. Amezcua-Vesely, B. D. Sather, A. K. Singh, S. Khim, J. Mucci, D. Liggitt, et al. 2013. Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORgt and Ahr that leads to IL-17 production by activated B cells. Nat. Immunol. 14: 514-522.
5. Shen, P., T. Roch, V. Lampropoulou, R. A. O'Connor, U. Stervbo, E. Hilgenberg, S. Ries, V. D. Dang, Y. Jaimes, C. Daridon, et al. 2014. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507: 366-370.
6. Dang, V. D., E. Hilgenberg, S. Ries, P. Shen, and S. Fillatreau. 2014. From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets. Curr. Opin. Immunol. 28: 77-83.
7. Crow, Y. J. 2015. Type I interferonopathies: mendelian type I interferon upregulation. Curr. Opin. Immunol. 32: 7-12.
8. Neves, P., V. Lampropoulou, E. Calderon-Gomez, T. Roch, U. Stervbo, P. Shen, A. A. Kuhl, C. Loddenkemper, M. Haury, S. A. Nedospasov, et al. 2010. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33: 777-790.
9. Xue, J., S. V. Schmidt, J. Sander, A. Draffehn, W. Krebs, I. Quester, D. De Nardo, T. D. Gohel, M. Emde, L. Schmidleithner, et al. 2014. Transcriptomebased network analysis reveals a spectrum model of human macrophage activation. Immunity 40: 274-288.
10. Crow, M. K. 2014. Type I interferon in the pathogenesis of lupus. J. Immunol. 192: 5459-5468.
11. Jego, G., A. K. Palucka, J. P. Blanck, C. Chalouni, V. Pascual, and J. Banchereau. 2003. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19: 225-234.
12. Cocco, M., S. Stephenson, M. A. Care, D. Newton, N. A. Barnes, A. Davison, A. Rawstron, D. R. Westhead, G. M. Doody, and R. M. Tooze. 2012. In vitro generation of long-lived human plasma cells. J. Immunol. 189: 5773-5785.
13. Jourdan, M., A. Caraux, J. De Vos, G. Fiol, M. Larroque, C. Cognot, C. Bret, C. Duperray, D. Hose, and B. Klein. 2009. An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization. Blood 114: 5173-5181.
14. Jourdan, M., M. Cren, N. Robert, K. Bolloré, T. Fest, C. Duperray, F. Guilloton, D. Hose, K. Tarte, and B. Klein. 2014. IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors. Leukemia 28: 1647-1656.
15. Ray, A., L. Wang, and B. N. Dittel. 2015. IL-10-independent regulatory B-cell subsets and mechanisms of action. Int. Immunol. 27: 531-536.
16. Morales, D. J., and D. J. Lenschow. 2013. The antiviral activities of ISG15. J. Mol. Biol. 425: 4995-5008.
17. Recht, M., E. C. Borden, and E. Knight Jr. 1991. A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J. Immunol. 147: 2617-2623.
18. D'Cunha, J., E. Knight Jr., A. L. Haas, R. L. Truitt, and E. C. Borden. 1996. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc. Natl. Acad. Sci. USA 93: 211-215.
19. Bogunovic, D., M. Byun, L. A. Durfee, A. Abhyankar, O. Sanal, D. Mansouri, S. Salem, I. Radovanovic, A. V. Grant, P. Adimi, et al. 2012. Mycobacterial disease and impaired IFN-g immunity in humans with inherited ISG15 deficiency. Science 337: 1684-1688.
20. Zhang, X., D. Bogunovic, B. Payelle-Brogard, V. Francois-Newton, S. D. Speer, C. Yuan, S. Volpi, Z. Li, O. Sanal, D. Mansouri, et al. 2015. Human intracellular ISG15 prevents interferon-a/b over-amplification and auto-inflammation. Nature 517: 89-93.
21. Du, P., W. A. Kibbe, and S. M. Lin. 2008. lumi: A pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548.
22. Gray, K. A., L. C. Daugherty, S. M. Gordon, R. L. Seal, M. W. Wright, and E. A. Bruford. 2013. Genenames.org: The HGNC resources in 2013. Nucleic Acids Res. 41: D545-D552.
23. Ritchie, M. E., B. Phipson, D. Wu, Y. Hu, C. W. Law, W. Shi, and G. K. Smyth. 2015. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43: E47.
24. Langfelder, P., and S. Horvath. 2008. WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 9: 559.
25. Bastian, M., S. Heymann, and M. Jacomy. 2009. Gephi : An Open Source Software for Exploring and Manipulating Networks. In Third International AAAI Conference on Weblogs and Social Media, May 17-20. AAAI Publications, San Jose, CA, p. 361-362.
26. Subramanian, A., P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander, and J. P. Mesirov. 2005. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102: 15545-15550.
27. Culhane, A. C., T. Schwarzl, R. Sultana, K. C. Picard, S. C. Picard, T. H. Lu, K. R. Franklin, S. J. French, G. Papenhausen, M. Correll, and J. Quackenbush. 2010. GeneSigDB-a curated database of gene expression signatures. Nucleic Acids Res. 38: D716-D725.
28. Shaffer, A. L., G. Wright, L. Yang, J. Powell, V. Ngo, L. Lamy, L. T. Lam, R. E. Davis, and L. M. Staudt. 2006. A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol. Rev. 210: 67-85.
29. Berry, M. P., C. M. Graham, F. W. McNab, Z. Xu, S. A. Bloch, T. Oni, K. A. Wilkinson, R. Banchereau, J. Skinner, R. J. Wilkinson, et al. 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
30. Chiche, L., N. Jourde-Chiche, E. Whalen, S. Presnell, V. Gersuk, K. Dang, E. Anguiano, C. Quinn, S. Burtey, Y. Berland, et al. 2014. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheumatol. 66: 1583-1595.
31. Li, S., N. Rouphael, S. Duraisingham, S. Romero-Steiner, S. Presnell, C. Davis, D. S. Schmidt, S. E. Johnson, A. Milton, G. Rajam, et al. 2014. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 15: 195-204.
32. Compagno, M., W. K. Lim, A. Grunn, S. V. Nandula, M. Brahmachary, Q. Shen, F. Bertoni, M. Ponzoni, M. Scandurra, A. Califano, et al. 2009. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 459: 717-721.
33. Huang, X., B. Meng, J. Iqbal, B. B. Ding, A. M. Perry, W. Cao, L. M. Smith, C. Bi, C. Jiang, T. C. Greiner, et al. 2013. Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP. J. Clin. Oncol. 31: 4520-4528.
34. Ngo, V. N., R. M. Young, R. Schmitz, S. Jhavar, W. Xiao, K. H. Lim, H. Kohlhammer, W. Xu, Y. Yang, H. Zhao, et al. 2011. Oncogenically active MYD88 mutations in human lymphoma. Nature 470: 115-119.
35. Rosenwald, A., G. Wright, K. Leroy, X. Yu, P. Gaulard, R. D. Gascoyne, W. C. Chan, T. Zhao, C. Haioun, T. C. Greiner, et al. 2003. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J. Exp. Med. 198: 851-862.
36. Zougman, A., P. J. Selby, and R. E. Banks. 2014. Suspension trapping (STrap) sample preparation method for bottom-up proteomics analysis. Proteomics 14: 1006-1000.
37. Reinhardt, R. L., H. E. Liang, and R. M. Locksley. 2009. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat. Immunol. 10: 385-393.
38. Baechler, E. C., F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, et al. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100: 2610-2615.
39. Bennett, L., A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197: 711-723.
40. Crow, M. K., K. A. Kirou, and J. Wohlgemuth. 2003. Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 36: 481-490.
41. Han, G. M., S. L. Chen, N. Shen, S. Ye, C. D. Bao, and Y. Y. Gu. 2003. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun. 4: 177-186.
42. Nutt, S. L., P. D. Hodgkin, D. M. Tarlinton, and L. M. Corcoran. 2015. The generation of antibody-secreting plasma cells. Nat. Rev. Immunol. 15: 160-171.
43. Doering, T. A., A. Crawford, J. M. Angelosanto, M. A. Paley, C. G. Ziegler, and E. J. Wherry. 2012. Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. Immunity 37: 1130-1144.
44. Pengo, N., M. Scolari, L. Oliva, E. Milan, F. Mainoldi, A. Raimondi, C. Fagioli, A. Merlini, E. Mariani, E. Pasqualetto, et al. 2013. Plasma cells require autophagy for sustainable immunoglobulin production. Nat. Immunol. 14: 298-305.
45. Béguelin, W., R. Popovic, M. Teater, Y. Jiang, K. L. Bunting, M. Rosen, H. Shen, S. N. Yang, L. Wang, T. Ezponda, et al. 2013. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell 23: 677-692.
46. Caganova, M., C. Carrisi, G. Varano, F. Mainoldi, F. Zanardi, P. L. Germain, L. George, F. Alberghini, L. Ferrarini, A. K. Talukder, et al. 2013. Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis. J. Clin. Invest. 123: 5009-5022.
47. Velichutina, I., R. Shaknovich, H. Geng, N. A. Johnson, R. D. Gascoyne, A. M. Melnick, and O. Elemento. 2010. EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. Blood 116: 5247-5255.
48. Grandér, D., and P. Johnsson. 2016. Pseudogene-Expressed RNAs: Emerging Roles in Gene Regulation and Disease. Curr. Top. Microbiol. Immunol. 394: 111-126.
49. Yoshino, S., T. Satoh, M. Yamada, K. Hashimoto, T. Tomaru, A. Katano-Toki, S. Kakizaki, S. Okada, H. Shimizu, A. Ozawa, et al. 2014. Protection against high-fat diet-induced obesity in Helz2-deficient male mice due to enhanced expression of hepatic leptin receptor. Endocrinology 155: 3459-3472.
50. Katano-Toki, A., T. Satoh, T. Tomaru, S. Yoshino, T. Ishizuka, S. Ishii, A. Ozawa, N. Shibusawa, T. Tsuchiya, T. Saito, et al. 2013. THRAP3 interacts with HELZ2 and plays a novel role in adipocyte differentiation. Mol. Endocrinol. 27: 769-780.
51. Kroll, J., X. Shi, A. Caprioli, H. H. Liu, C. Waskow, K. M. Lin, T. Miyazaki, H. R. Rodewald, and T. N. Sato. 2005. The BTB-kelch protein KLHL6 is involved in B-lymphocyte antigen receptor signaling and germinal center formation. Mol. Cell. Biol. 25: 8531-8540.
52. Puente, X. S., M. Pinyol, V. Quesada, L. Conde, G. R. Ordóñez, N. Villamor, G. Escaramis, P. Jares, S. Beà, M. González-Díaz, et al. 2011. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475: 101-105.
53. Choe, J., H. S. Kim, X. Zhang, R. J. Armitage, and Y. S. Choi. 1996. Cellular and molecular factors that regulate the differentiation and apoptosis of germinal center B cells. Anti-Ig down-regulates Fas expression of CD40 ligand-stimulated germinal center B cells and inhibits Fas-mediated apoptosis. J. Immunol. 157: 1006-1016.
54. Choe, J., H. S. Kim, R. J. Armitage, and Y. S. Choi. 1997. The functional role of B cell antigen receptor stimulation and IL-4 in the generation of human memory B cells from germinal center B cells. J. Immunol. 159: 3757-3766.
55. Choe, J., and Y. S. Choi. 1998. IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells. Eur. J. Immunol. 28: 508-515.
56. Lenschow, D. J., C. Lai, N. Frias-Staheli, N. V. Giannakopoulos, A. Lutz, T. Wolff, A. Osiak, B. Levine, R. E. Schmidt, A. García-Sastre, et al. 2007. IFNstimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl. Acad. Sci. USA 104: 1371-1376.
57. Giannakopoulos, N. V., J. K. Luo, V. Papov, W. Zou, D. J. Lenschow, B. S. Jacobs, E. C. Borden, J. Li, H. W. Virgin, and D. E. Zhang. 2005. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem. Biophys. Res. Commun. 336: 496-506.
58. Zhao, C., C. Denison, J. M. Huibregtse, S. Gygi, and R. M. Krug. 2005. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. USA 102: 10200-10205.
59. Knight, E. Jr., and B. Cordova. 1991. IFN-induced 15-kDa protein is released from human lymphocytes and monocytes. J. Immunol. 146: 2280-2284.
60. D'Cunha, J., S. Ramanujam, R. J. Wagner, P. L. Witt, E. Knight Jr., and E. C. Borden. 1996. In vitro and in vivo secretion of human ISG15, an IFNinduced immunomodulatory cytokine. J. Immunol. 157: 4100-4108.
61. Yaniv, G., G. Twig, D. B. Shor, A. Furer, Y. Sherer, O. Mozes, O. Komisar, E. Slonimsky, E. Klang, E. Lotan, et al. 2015. A volcanic explosion of autoantibodies in systemic lupus erythematosus: A diversity of 180 different antibodies found in SLE patients. Autoimmun. Rev. 14: 75-79.
62. Kamal, A., and M. Khamashta. 2014. The efficacy of novel B cell biologics as the future of SLE treatment: A review. Autoimmun. Rev. 13: 1094-1101.
63. Steiman, A. J., M. B. Urowitz, D. Ibañez, T. T. Li, D. D. Gladman, and J. Wither. 2015. Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus. J. Rheumatol. 42: 810- 816.
64. Furie, R., M. Petri, O. Zamani, R. Cervera, D. J. Wallace, D. Tegzová, J. Sanchez-Guerrero, A. Schwarting, J. T. Merrill, W. W. Chatham, et al; BLISS-76 Study Group. 2011. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum. 63: 3918-3930.
65. Tew, G. W., N. Rabbee, K. Wolslegel, H. J. Hsieh, J. G. Monroe, T. W. Behrens, P. G. Brunetta, and M. E. Keir. 2010. Baseline autoantibody profiles predict normalization of complement and anti-dsDNA autoantibody levels following rituximab treatment in systemic lupus erythematosus. Lupus 19: 146-157.
66. Shi, W., Y. Liao, S. N. Willis, N. Taubenheim, M. Inouye, D. M. Tarlinton, G. K. Smyth, P. D. Hodgkin, S. L. Nutt, and L. M. Corcoran. 2015. Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells. Nat. Immunol. 16: 663-673.
67. Okumura, F., W. Zou, and D. E. Zhang. 2007. ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP. Genes Dev. 21: 255-260.
68. Shi, H. X., K. Yang, X. Liu, X. Y. Liu, B. Wei, Y. F. Shan, L. H. Zhu, and C. Wang. 2010. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol. Cell. Biol. 30: 2424-2436.
69. Dangelmaier, C. A., P. G. Quinter, J. Jin, A. Y. Tsygankov, S. P. Kunapuli, and J. L. Daniel. 2005. Rapid ubiquitination of Syk following GPVI activation in platelets. Blood 105: 3918-3924.
70. Fleischer, S. J., C. Giesecke, H. E. Mei, P. E. Lipsky, C. Daridon, and T. Dörner. 2014. Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus. Arthritis Rheumatol. 66: 3424-3435.
71. Harigai, M., M. Kawamoto, M. Hara, T. Kubota, N. Kamatani, and N. Miyasaka. 2008. Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B. J. Immunol. 181: 2211- 2219.
72. Karonitsch, T., E. Feierl, C. W. Steiner, K. Dalwigk, A. Korb, N. Binder, A. Rapp, G. Steiner, C. Scheinecker, J. Smolen, and M. Aringer. 2009. Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells. Arthritis Rheum. 60: 1463-1471.
73. Bauer, J. W., M. Petri, F. M. Batliwalla, T. Koeuth, J. Wilson, C. Slattery, A. Panoskaltsis-Mortari, P. K. Gregersen, T. W. Behrens, and E. C. Baechler. 2009. Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study. Arthritis Rheum. 60: 3098-3107.
74. Becker, A. M., K. H. Dao, B. K. Han, R. Kornu, S. Lakhanpal, A. B. Mobley, Q. Z. Li, Y. Lian, T. Wu, A. M. Reimold, et al. 2013. SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature. PLoS One 8: E67003.
75. Scapini, P., C. Lamagna, Y. Hu, K. Lee, Q. Tang, A. L. DeFranco, and C. A. Lowell. 2011. B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice. Proc. Natl. Acad. Sci. USA 108: E823-E832.
76. Rauch, P. J., A. Chudnovskiy, C. S. Robbins, G. F. Weber, M. Etzrodt, I. Hilgendorf, E. Tiglao, J. L. Figueiredo, Y. Iwamoto, I. Theurl, et al. 2012. Innate response activator B cells protect against microbial sepsis. Science 335: 597-601.
77. Winter, O., C. Dame, F. Jundt, and F. Hiepe. 2012. Pathogenic long-lived plasma cells and their survival niches in autoimmunity, malignancy, and allergy. J. Immunol. 189: 5105-5111.
78. Cerutti, A., M. Cols, and I. Puga. 2012. Activation of B cells by non-canonical helper signals. EMBO Rep. 13: 798-810.
79. Vinuesa, C. G., and P. P. Chang. 2013. Innate B cell helpers reveal novel types of antibody responses. Nat. Immunol. 14: 119-126.